BRUNK GERALD A 4
4 · enGene Holdings Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
BRUNK GERALD A
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-15+20,000→ 20,000 totalExercise: $9.00Exp: 2034-06-15→ Common Shares (20,000 underlying)
Footnotes (2)
- [F1]This option fully vests on the earlier of (i) the first anniversary of the date vesting commenced, which was May 15, 2024; or (ii) the 2025 Annual Meeting of Shareholders.
- [F2]These options are held of record by Mr. Brunk for the benefit of Lumira Ventures III, L.P. ("Lumira III"), Lumira Ventures III (International), L.P. ("Lumira III Int'l"), Lumira Ventures IV, L.P. ("Lumira IV"), Lumira Ventures IV (International), L.P. ("Lumira IV Int'l"), Merck Lumira Biosciences Fund, L.P. ("Merck-Lumira"), Merck Lumira Biosciences Fund (Quebec), L.P. ("Merck-Lumira B" and, together with Lumira III, Lumira III Int'l, Lumira IV, Lumira IV Int'l, and Merck-Lumira, the "Lumira Entities"). Mr. Brunk expressly disclaims beneficial ownership of these securities.